Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-05-09FDA Approved: DAYPRO — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for DAYPRO (oxaprozin) from Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2016-05-09FDA Approved: DICLOFENAC SODIUM AND MISOPROSTOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for diclofenac sodium and misoprostol from Mylan Pharmaceuticals Inc., marking an approved chang…
-
FDA approval · 2016-05-09FDA Approved: NABUMETONE — Supplemental Application (Exelan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Nabumetone from Exelan Pharmaceuticals Inc. This action typically updates labeling or adds a…
-
FDA approval · 2016-05-09FDA Approved: NABUMETONE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Nabumetone filed by Lupin Pharmaceuticals, indicating an update to the drug's labeling or fo…
-
FDA label_change · 2016-05-09FDA Approved: DIFLUNISAL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for DIFLUNISAL (diflunisal) from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., indi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: Rhupus Syndrome and Efficacy of Etanercept Treatment
A completed clinical trial evaluated the efficacy of etanercept in rhupus syndrome, an overlap of rheumatoid arthritis and systemic lupus er…
-
FDA approval · 2016-05-09FDA Approved: SULINDAC — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Sulindac from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2016-05-09FDA Approved: ETODOLAC — Supplemental Application (Apotex Corp.)
FDA approves a supplemental application for etodolac by Apotex Corp., updating the approval status of this generic NSAID.
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: Marine Oils and Arthritis [NA]
A clinical trial evaluating marine oils for rheumatoid arthritis was terminated; no definitive results are reported in this update.
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Action of AMG 357 in Females With Rheumatoid Arthritis [Phase 1]
The document reports termination of a Phase 1 study evaluating AMG 357 in females with rheumatoid arthritis, focusing on safety, tolerabilit…
-
FDA approval · 2016-05-05FDA Approved: TYLENOL 8 HR ARTHRITIS PAIN — Supplemental Application (Kenvue Brands LLC)
The FDA approved a supplemental application for TYLENOL 8 HR ARTHRITIS PAIN (acetaminophen) submitted by Kenvue Brands LLC.
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: A Study of the Safety, Tolerability and Pharmacokinetics of HMPL-523 [Phase 1]
Phase 1 study of HMPL-523 in rheumatoid arthritis has completed, assessing safety, tolerability, and pharmacokinetics.
-
CLINICAL_TRIALS research · 2016-04-28Clinical Trial Update: Preconceptional Counselling in Active Rheumatoid Arthritis
This clinical trial update concerns preconception counseling for individuals with active rheumatoid arthritis. It references rheumatoid arth…
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Iyengar Yoga for Young People With Rheumatoid Arthritis [NA]
ClinicalTrials.gov reports that the trial evaluating Iyengar Yoga in young people with rheumatoid arthritis has completed and posted results…
-
EMA withdrawal · 2016-04-21EMA Withdrawn: Repso (leflunomide) — Teva B.V.
The EMA has withdrawn Repso (leflunomide) from the market, a disease-modifying antirheumatic drug previously used for rheumatoid arthritis a…
-
CLINICAL_TRIALS trial_result · 2016-04-21Clinical Trial Update: Long-term Clinical Effectiveness of the Delta Xtend Reverse Total Shoulder [NA]
A terminated long-term clinical study evaluated the effectiveness of the Delta Xtend reverse total shoulder prosthesis across several should…
-
CLINICAL_TRIALS trial_result · 2016-04-21Clinical Trial Update: An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Sero-Positive Rheumatoid Arthritis Who Are Non-Responders or Intolerant to a Single TNF-Inhibitor (PORTSMAB)
An observational study evaluating Rituximab (Rituxan/MabThera) in seropositive rheumatoid arthritis patients who did not respond to or could…
-
FDA approval · 2016-04-20FDA Approved: MELOXICAM — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for MELOXICAM submitted by Zydus Pharmaceuticals USA Inc. This action constitutes a supplemental…
-
CLINICAL_TRIALS research · 2016-04-19Clinical Trial Update: Multiple Doses Escalation Study of SHR0302 in Rheumatoid Arthritis (RA) Patients [Phase 1]
A Phase 1 dose-escalation trial update of SHR0302 in rheumatoid arthritis, outlining ongoing activities and enrollment status.
-
CLINICAL_TRIALS research · 2016-04-19Clinical Trial Update: Identification of Epigenetic Biomarkers for Early Detection of Rheumatic Disease
Clinical trial update on identifying epigenetic biomarkers for the early detection of rheumatic diseases, including rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis [Phase 2]
A Phase 2 dose-ranging trial (VELVET) evaluating veltuzumab in adults with moderate to severe rheumatoid arthritis was terminated.
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: A Randomised Trial Comparing Anterior Versus Posterior Approach in Total Hip Replacement [NA]
The randomized trial comparing anterior versus posterior approach in total hip replacement has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis [Phase 2]
This Phase 2 trial provides long-term safety data for ATN-103 in rheumatoid arthritis patients and has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis [Phase 3]
This update summarizes a Phase 3 study of NI-071 in rheumatoid arthritis, noting that the trial has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-07Clinical Trial Update: Sarilumab Effect on the Pharmacokinetics of Simvastatin [Phase 1]
Phase 1 study investigating the pharmacokinetic interaction between sarilumab and simvastatin in rheumatoid arthritis patients; results summ…